NeoGenomics, Inc. Proceeds from (Repayments of) Restricted Cash, Financing Activities
NeoGenomics, Inc. (NEO) reported Proceeds from (Repayments of) Restricted Cash, Financing Activities of $500.00 thousand for the 12-month period ending 2012-12-31, per its 10-K filed 2015-03-03.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromRepaymentsOfRestrictedCashFinancingActivities · last filed 2015-03-03
- NeoGenomics, Inc. proceeds from (repayments of) restricted cash, financing activities for the quarter ending 2012-12-31 was $300.00K.
- NeoGenomics, Inc. proceeds from (repayments of) restricted cash, financing activities for the quarter ending 2012-09-30 was $0.00.
- NeoGenomics, Inc. proceeds from (repayments of) restricted cash, financing activities for the quarter ending 2012-06-30 was $0.00.
- NeoGenomics, Inc. proceeds from (repayments of) restricted cash, financing activities for the quarter ending 2012-03-31 was $200.00K.
- NeoGenomics, Inc. proceeds from (repayments of) restricted cash, financing activities for fiscal 2012 was $500.00K.
- NeoGenomics, Inc. proceeds from (repayments of) restricted cash, financing activities for fiscal 2010 was $500.00K.
| Period end | Proceeds from (Repayments of) Restricted Cash, Financing Activities 3 month | Proceeds from (Repayments of) Restricted Cash, Financing Activities 6 month | Proceeds from (Repayments of) Restricted Cash, Financing Activities 9 month | Proceeds from (Repayments of) Restricted Cash, Financing Activities 12 month |
|---|---|---|---|---|
| 2012-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-03 | $300.00K derived: sum of 2 quarters · filed 2015-03-03 | $300.00K derived: sum of 3 quarters · filed 2015-03-03 | $500.00K 10-K · filed 2015-03-03 |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-30 | $0.00 derived: sum of 2 quarters · filed 2013-10-30 | $200.00K 10-Q · filed 2013-10-30 | |
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-02 | $200.00K 10-Q · filed 2013-08-02 | ||
| 2012-03-31 | $200.00K 10-Q · filed 2013-05-13 | |||
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-12 | $0.00 derived: sum of 2 quarters · filed 2012-03-12 | $500.00K 10-K · filed 2012-03-12 | |
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-10-25 | $500.00K 10-Q · filed 2011-10-25 | ||
| 2010-06-30 | $500.00K 10-Q/A · filed 2011-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |